Half Year 2024 Redcare Pharmacy NV Earnings Call Transcript
Thank you very much and good morning to everybody. Also very warm welcome from my side. As some of you who are joining via webcast, probably just saw commercials on our X. We are currently running. So we thought this is a nice intro and the other day.
So let's have a look into the agenda of today. The standard agenda. Firstly, Scott, with financial performance during the strategy update on 2024 and outlook and guidance. If we look into the financial performance, we would like to start with some highlights from We continue our fast grow at a 42%. And even if we exclude managed services, we are showing a growth above 20%. So to be more specific, it's 21% we are very happy to report strong growth on Europe, as you all aware of and direct became mandatory at the beginning of this year. And since then, we have seen really great adaptation from a doctor's perspective. So more than 80% of the scripts being issued in Germany are already difficult since the launch of our cutting solution on May sixth, we have seen
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |